Cargando…

Growth factors in ovarian cancer.

Epidermal growth factor and transforming growth factor alpha are two peptides which bind to the epidermal growth factor receptor. One hundred and seventy-four samples from 133 patients with ovarian cancer were examined for EGF and TGF alpha. EGF was detected in only 27.6% of samples while TGF alpha...

Descripción completa

Detalles Bibliográficos
Autores principales:	Owens, O. J., Stewart, C., Leake, R. E.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1991
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1977857/ https://www.ncbi.nlm.nih.gov/pubmed/1764384

Ejemplares similares

Epidermal growth factor receptors (EGFR) in human ovarian cancer.
por: Owens, O. J., et al.
Publicado: (1991)

Inhibition of transforming growth factor α (TGF-α)-mediated growth effects in ovarian cancer cell lines by a tyrosine kinase inhibitor ZM 252868
por: Simpson, B J B, et al.
Publicado: (1999)

Interleukin-2 receptor and ovarian cancer.
por: Owens, O. J., et al.
Publicado: (1993)

The prognostic value of epidermal growth factor receptor mRNA expression in primary ovarian cancer.
por: Bartlett, J. M., et al.
Publicado: (1996)

Concentration of vascular endothelial growth factor (VEGF) in the serum of patients with suspected ovarian cancer.
por: Obermair, A., et al.
Publicado: (1998)

Dietary factors and epithelial ovarian cancer.
por: Shu, X. O., et al.
Publicado: (1989)

Prognostic Values of Transforming Growth Factor-Beta Subtypes in Ovarian Cancer
por: Zhou, Junhan, et al.
Publicado: (2020)

Review: Targeting the Transforming Growth Factor-Beta Pathway in Ovarian Cancer
por: Roane, Brandon M., et al.
Publicado: (2019)

Ginger inhibits cell growth and modulates angiogenic factors in ovarian cancer cells
por: Rhode, Jennifer, et al.
Publicado: (2007)

Clinical significance of heparin-binding epidermal growth factor-like growth factor in peritoneal fluid of ovarian cancer
por: Yagi, H, et al.
Publicado: (2005)

Effect of BRCA1 on epidermal growth factor receptor in ovarian cancer
por: Li, Da, et al.
Publicado: (2013)

Growth differentiation factor 15 stimulates rapamycin-sensitive ovarian cancer cell growth and invasion
por: Griner, Samantha E., et al.
Publicado: (2012)

Modulation of the proliferative response of breast cancer cells to growth factors by oestrogen.
por: Stewart, A. J., et al.
Publicado: (1992)

Significance of vascular endothelial growth factor in growth and peritoneal dissemination of ovarian cancer
por: Masoumi Moghaddam, Samar, et al.
Publicado: (2011)

Follicular fluid placental growth factor is increased in polycystic ovarian syndrome: correlation with ovarian stimulation
por: Tal, Reshef, et al.
Publicado: (2014)

Epidermal growth factor receptor in ovarian tumours: correlation of immunohistochemistry with ligand binding assay.
por: Henzen-Logmans, S. C., et al.
Publicado: (1992)

Transforming Growth Factor-β and Nitrates in Epithelial Ovarian Cancer
por: Khalifa, Ali, et al.
Publicado: (1999)

Nerve growth factor and its receptors on onset and diagnosis of ovarian cancer
por: Yu, Xiaolin, et al.
Publicado: (2017)

Leukemia Inhibitory Factor Functions in Parallel with Interleukin-6 to Promote Ovarian Cancer Growth
por: McLean, Karen, et al.
Publicado: (2018)

Transforming growth factor-beta mRNA expression and growth control of human ovarian carcinoma cells.
por: Bartlett, J. M., et al.
Publicado: (1992)

STAMP alters the growth of transformed and ovarian cancer cells
por: He, Yuanzheng, et al.
Publicado: (2010)

Hepatoma-derived growth factor predicts unfavorable prognosis of epithelial ovarian cancer
por: Liu, Xue-jun, et al.
Publicado: (2015)

Contributions of the Epidermal Growth Factor Receptor to Acquisition of Platinum Resistance in Ovarian Cancer Cells
por: Granados, Michaela L., et al.
Publicado: (2015)

The Prognostic Values of the Insulin-Like Growth Factor Binding Protein Family in Ovarian Cancer
por: Zheng, Ruoyi, et al.
Publicado: (2020)

Role of Insulin-like Growth Factor, Insulin-like Growth Factor Receptors, and Insulin-like Growth Factor-binding Proteins in Ovarian Cancer
por: Amutha, Periyasamy, et al.
Publicado: (2017)

Transactivation of epidermal growth factor receptor through platelet-activating factor/receptor in ovarian cancer cells
por: Yu, Yi, et al.
Publicado: (2014)

Role of nerve growth factor and its TRKA receptor in normal ovarian and epithelial ovarian cancer angiogenesis
por: Vera, Carolina, et al.
Publicado: (2014)

Insulin-like growth factor binding protein 2 promotes ovarian cancer cell invasion
por: Lee, Eun-Ju, et al.
Publicado: (2005)

Urine CA125 and HE4 for the Detection of Ovarian Cancer in Symptomatic Women
por: Barr, Chloe E., et al.
Publicado: (2023)

Fibroblast growth factor 21 is related to cisplatin resistance in ovarian cancer
por: Zhong, Qian, et al.
Publicado: (2022)

Prognostic significance of vascular endothelial growth factor expression in human ovarian carcinoma
por: Shen, G H, et al.
Publicado: (2000)

Ex vivo expanded tumour-infiltrating lymphocytes from ovarian cancer patients release anti-tumour cytokines in response to autologous primary ovarian cancer cells
por: Owens, Gemma L., et al.
Publicado: (2018)

Clinical implications of expression of vascular endothelial growth factor in metastatic lesions of ovarian cancers
por: Fujimoto, J, et al.
Publicado: (2001)

Targeting the Epidermal Growth Factor Receptor in Epithelial Ovarian Cancer: Current Knowledge and Future Challenges
por: Siwak, Doris R., et al.
Publicado: (2010)

Targeting Insulin and Insulin-Like Growth Factor Pathways in Epithelial Ovarian Cancer
por: Beauchamp, Marie-Claude, et al.
Publicado: (2010)

Tumour antigenicity in ovarian cancer.
por: Levin, L., et al.
Publicado: (1975)

Urinary biomarkers for the detection of ovarian cancer: a systematic review
por: Owens, Gemma L, et al.
Publicado: (2022)

Insulin-Like Growth Factor 2 Silencing Restores Taxol Sensitivity in Drug Resistant Ovarian Cancer
por: Brouwer-Visser, Jurriaan, et al.
Publicado: (2014)

An IL6-correlated signature in serous epithelial ovarian cancer associates with growth factor response
por: Pinciroli, Patrizia, et al.
Publicado: (2013)

Curcumin induces chemo/radio-sensitization in ovarian cancer cells and curcumin nanoparticles inhibit ovarian cancer cell growth
por: Yallapu, Murali M, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_k5bg37ef3gn8fbfi5cmghhul2l